Question 1

What’s the financial overview for Hisamitsu Pharmaceutical Co., Inc.?

Accepted Answer

Hisamitsu Pharmaceutical Co., Inc.’s market cap stands at $0.002 trillion right now. The company’s trailing twelve-month earnings per share EPS is $1.82, with a dividend yield of 1.85%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Hisamitsu Pharmaceutical Co., Inc. Stock ROE tell us?

Accepted Answer

Hisamitsu Pharmaceutical Co., Inc. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for Hisamitsu Pharmaceutical Co., Inc.?

Accepted Answer

The Hisamitsu Pharmaceutical Co., Inc. stock per share price is $28.94.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$44.75B	$35.80B	$39.65B	$35.81B
Cost of Revenue	$19.95B	$13.82B	$16.04B	$15.005B
Gross Profit	$24.81B	$21.98B	$23.60B	$20.80B
Gross Profit Ratio	$0.55	$0.61	$0.60	$0.58
R&D Expenses	$0.00	$0.00	$2.75B	$2.35B
SG&A Expenses	$19.13B	$17.77B	$15.99B	$14.30B
Operating Expenses	$19.13B	$17.77B	$18.75B	$16.66B
Total Costs & Expenses	$39.08B	$31.58B	$34.79B	$31.66B
Interest Income	$576.00M	$0.00	$733.00M	$728.00M
Interest Expense	$8.00M	$0.00	$12.00M	$4.00M
Depreciation & Amortization	$1.83B	$1.52B	$1.58B	$1.41B
EBITDA	$11.11B	$5.71B	$7.78B	$6.92B
EBITDA Ratio	$0.25	$0.16	$0.20	$0.19
Operating Income	$5.67B	$4.21B	$4.86B	$4.15B
Operating Income Ratio	$0.13	$0.12	$0.12	$0.12
Other Income/Expenses (Net)	$3.60B	$2.10B	$1.33B	$2.77B
Income Before Tax	$9.28B	$6.31B	$6.19B	$6.92B
Income Before Tax Ratio	$0.21	$0.18	$0.16	$0.19
Income Tax Expense	$1.03B	$1.65B	$1.76B	$1.94B
Net Income	$8.10B	$4.56B	$4.31B	$4.79B
Net Income Ratio	$0.18	$0.13	$0.11	$0.13
EPS	$110.56	$62.22	$58.68	$63.89
Diluted EPS	$110.56	$62.22	$58.68	$63.81
Weighted Avg Shares Outstanding	$73.25M	$73.32M	$73.46M	$74.94M
Weighted Avg Shares Outstanding (Diluted)	$73.25M	$73.32M	$73.45M	$75.03M

Hisamitsu Pharmaceutical Co., Inc.